Georgia Powell is an associate in Goodwin’s Technology and Life Sciences group. Dr. Powell has experience in advising on a range of non-contentious intellectual property and commercial matters, with a focus on the life sciences, technology and healthcare sectors. She works on transactions including licences, collaborations, distribution, manufacturing and R&D projects, as well as regulatory matters, early- stage contract disputes, and commercial and IP aspects of M&A transactions.
Prior to joining Goodwin in 2019, Dr. Powell was a senior associate at Taylor Wessing LLP.
Experience
- Advised SynAffix and its selling shareholders on its sale to Lonza. Under the terms of the sale and purchase agreement, Lonza have paid Synaffix’s shareholders an upfront payment of €100 million, with the potential for shareholders to receive an additional payment of up to €60 million contingent on financial performance
Areas of Practice
Credentials
Education
PGDip in IP Law and Practice2014
Oxford University
Graduate Diploma in Law2010
BPP Law School
Legal Practice Course2009
BPP Law School
PhDMolecular Genetics2009
King's College London
MSc2005
King's College London
BA (Honours)Philosophy2003
Cambridge University
Admissions
Courts
- Solicitor of the Senior Courts of England and Wales
Recognition & Awards
- Dr. Powell was recognised by Chambers UK 2022 and 2023 as an Associate to Watch in the Intellectual Property East Anglia category. Clients cite her as an “excellent and hard-working team member”
- Dr. Powell was recognised by Legal 500 2020, 2021, and 2023 as a Rising Star in the Intellectual Property in Cambridge category. Client testimonials highlighted her ability in providing “reliable, solid advice”